Advanced Enzyme Technologies
ADVENZYMES · Pharma > Pharmaceuticals & Drugs · Chairman: Vasant Rathi Listing date: Aug. 2, 2016 · Employees: 750 · Thane · http://www.advancedenzymes.com

Stock Price vs Company Growth
1d
1.3%
1w
5.1%
1m
5.2%
3m
7.6%
6m
0.4%
1y
1.2%
5y
3.0%
all
3.5%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 306 1.3%
260
345
Company Overview

Sales
710 Cr
Growth: 14.2%
Profit after Tax
141 Cr
Growth: -4.3%
Small Cap
3,422 Cr
P/E: 22.5x
Industry P/E: 29.7x
Fundamentals

Sales (Cr) ₹ 710
Growth 14.2%
EBITDA 29.8%
P/S 4.8x
Dividend 1.3%
P/E 22.5x
Book Value ₹ 137
PEG Ratio 1.6x
ROE 9.5%
P/B 2.2x
Shareholding Pattern

Institutions
Orbimed Asia Iii Mauritius Limited
9.89 %
Nalanda India Equity Fund Limited
4.74 %
Hdfc Small Cap Fund
4.39 %
Orbimed Asia Iii Mauritius Fvci Limited
2.2 %
Icici Prudential Esg Fund
2.14 %
Promoters
Vasant Rathi
32.72 %
Advanced Vital Enzymes Private Limited
8.91 %
Reshma Namita Rathi
2.37 %
Rasika Vasant Rathi
2.36 %
Rachana Vasant Rathi
2.36 %
Others
Increase    Decrease    No change
Company Profile Detailed

The company is a fully integrated enzyme manufacturing company driven by extensive focus on research and development (R&D) of various enzymes, enzyme blends, enzyme products and customized enzyme solutions. Its experienced and qualified R&D team strives to develop creative, cost-effective unique and innovative solutions, thereby enabling their customers to develop superior products and processes.
Investors (87)
Followers (13)